Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Previous close
$321.57
+$0.62 · +0.19%
Regular session · ET · Market data may be delayed.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Day range
Current $321.57
52-week range
Current $321.57
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
91
Deep Value
Sentiment
60
Mixed
Risk
23
Moderate Risk
Momentum
43
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Day range
Current $321.57
52-week range
Current $321.57
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 321.33B USD | 293.96B USD | 262.17B USD | 238.59B USD | 213.99B USD |
| Cost of goods sold | 311.19B USD | 285.26B USD | 254.42B USD | 230.99B USD | 207.72B USD |
| Gross profit | 10.14B USD | 8.7B USD | 7.76B USD | 7.6B USD | 6.27B USD |
| Selling, general, and administrative | 6.49B USD | 5.66B USD | 5.31B USD | 4.85B USD | 3.59B USD |
| Operating expenses | 6.49B USD | 5.66B USD | 5.31B USD | 4.85B USD | 3.59B USD |
| Interest income | 128.21M USD | 91.69M USD | 46.72M USD | 21.31M USD | 8.47M USD |
| Interest expense | 419.75M USD | 248.68M USD | 275.65M USD | 231.98M USD | 182.54M USD |
| Depreciation and amortization | 1.06B USD | 1.11B USD | 972.39M USD | 697.94M USD | 505.17M USD |
| Operating income | 3.65B USD | 3.04B USD | 2.45B USD | 2.75B USD | 2.68B USD |
| Net income | 1.55B USD | 1.51B USD | 1.75B USD | 1.7B USD | 1.54B USD |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$358.14
11.37% upsideCash distributions grouped by calendar year; partial years are marked.
$2.25
2025 complete year-47.9% since 2021
2026 partial: $1.80
$4.32
2,021
$1.865
2,022
$1.965
2,023
$2.08
2,024
$2.25
2,025
$1.80
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 14, 2026 | $0.60Quarterly | Aug 14, 2026 | Aug 31, 2026 |
Dividend | May 15, 2026 | $0.60Quarterly | May 15, 2026 | Jun 1, 2026 |
Dividend | Feb 13, 2026 | $0.60Quarterly | Feb 13, 2026 | Mar 2, 2026 |
Dividend | Nov 14, 2025 | $0.60Quarterly | Nov 14, 2025 | Dec 1, 2025 |
Dividend | Aug 15, 2025 | $0.55Quarterly | Aug 15, 2025 | Sep 3, 2025 |
Dividend | May 16, 2025 | $0.55Quarterly | May 16, 2025 | Jun 2, 2025 |
Ex-dividend Aug 14, 2026
$0.60
Quarterly
Record Aug 14, 2026 · Payment Aug 31, 2026
Ex-dividend May 15, 2026
$0.60
Quarterly
Record May 15, 2026 · Payment Jun 1, 2026
Ex-dividend Feb 13, 2026
$0.60
Quarterly
Record Feb 13, 2026 · Payment Mar 2, 2026
Ex-dividend Nov 14, 2025
$0.60
Quarterly
Record Nov 14, 2025 · Payment Dec 1, 2025
Ex-dividend Aug 15, 2025
$0.55
Quarterly
Record Aug 15, 2025 · Payment Sep 3, 2025
Ex-dividend May 16, 2025
$0.55
Quarterly
Record May 16, 2025 · Payment Jun 2, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.83B0.08%2.3T USD0.03%$376.31+0.82%
Vanguard S&P 500 ETFVOO1.59B0.09%1.7T USD0.03%$702.56+0.85%
Vanguard Morningstar Mid-Cap ETFVO1.25B0.55%224.7B USD0.03%$81.03+0.78%
iShares Core S&P 500 ETFIVV806.39M0.10%839.6B USD0.03%$767.92+0.84%
State Street SPDR S&P 500 ETFSPY767.51M0.10%799.37B USD0.09%$764.29+0.85%
Vanguard Morningstar Value ETFVTV548.09M0.21%256.5B USD0.03%$223.97+0.72%
State Street Health Care Select Sector SPDR ETFXLV451.91M1.04%42.99B USD0.08%$165.36-0.18%
Vanguard Morningstar Mid-Cap Value ETFVOE370.46M0.95%38.6B USD0.05%$205.4+0.75%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Morningstar Mid-Cap Value ETFVOEAI-generated and delayed market data for informational and educational purposes only. Not investment advice.